Cartesian Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
852
across all filing types
Latest filing
2026-04-30
Registration Form
Country
US
United States of America
Listing
US
RNAC
Cartesian Therapeutics, Inc. is a clinical-stage company that pioneers the development of mRNA-engineered cell therapies. The company's primary focus is on creating treatments for autoimmune diseases. Leveraging its novel mRNA technology platform, Cartesian develops therapeutic cells designed to target the drivers of these conditions. This approach aims to expand the reach and potential of cell therapy for patients with various autoimmune disorders. The company's lead asset, Descartes-08, is a central component of its clinical pipeline.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-8 - Cartesian Therapeutics, Inc. (0001453687) (Filer) | 2026-04-30 | English | |
| 10-Q - Cartesian Therapeutics, Inc. (0001453687) (Filer) | 2026-04-30 | English | |
| 8-K - Cartesian Therapeutics, Inc. (0001453687) (Filer) | 2026-04-30 | English | |
| DEF 14A - Cartesian Therapeutics, Inc. (0001453687) (Filer) | 2026-04-28 | English | |
| 8-K - Cartesian Therapeutics, Inc. (0001453687) (Filer) | 2026-03-30 | English | |
| SCHEDULE 13G/A Filing | 2026-02-05 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39071982 | S-8 - Cartesian Therapeutics, Inc. (0001453687) (Filer) | 2026-04-30 | English | ||
| 39069786 | 10-Q - Cartesian Therapeutics, Inc. (0001453687) (Filer) | 2026-04-30 | English | ||
| 39069693 | 8-K - Cartesian Therapeutics, Inc. (0001453687) (Filer) | 2026-04-30 | English | ||
| 37972248 | DEF 14A - Cartesian Therapeutics, Inc. (0001453687) (Filer) | 2026-04-28 | English | ||
| 33093345 | 8-K - Cartesian Therapeutics, Inc. (0001453687) (Filer) | 2026-03-30 | English | ||
| 29883044 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 29883208 | 8-K Filing | 2026-01-09 | English | ||
| 29883103 | 4 Filing | 2026-01-08 | English | ||
| 29883080 | 4 Filing | 2026-01-08 | English | ||
| 29883054 | 4 Filing | 2026-01-08 | English | ||
| 12264441 | FORM 4 | 2026-01-06 | English | ||
| 12264440 | FORM 4 | 2026-01-06 | English | ||
| 12264433 | FORM 4 | 2026-01-06 | English | ||
| 12264438 | FORM 4 | 2026-01-06 | English | ||
| 12264432 | FORM 4 | 2026-01-06 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
Cartesian Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33483/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33483 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33483 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33483 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33483}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cartesian Therapeutics, Inc. (id: 33483)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.